J&J gets FDA authorization for Ottava robot, teeing up competition with Intuitive

Johnson & Johnson received FDA authorization for its Ottava robotic surgery system, marking significant competition against market leader Intuitive Surgical in the U.S. robotic surgery market. Analysts question whether the system will capture meaningful market share from Intuitive's dominant position.